By An Open Letter to Dr. Mokgethi, Gauteng MEC for Health About a month ago, I wrote an open letter to Dr. Nolutshungu, the new head of department for the Gauteng Department of Health. The letter had the desired effect, with Dr. Mokgethi answering some of the questions on her colleague’s
Is the Revolutionary New Late-Stage Breast Cancer Drug, Enhertu®, Beneficial in a South African Context?
Social media has been buzzing with news of the revolutionary new breast cancer drug, Enhertu®, and how it will be able to extend and enhance the lives of late-stage and metastatic breast cancer survivors. Make no mistake, this is great news but, in a South African context, how beneficial is Enhertu® really?
Due to the Oncology Crisis in Gauteng Public Hospitals, Is There Any Hope Left for Inflammatory Breast Cancer Patients in South Africa?
Due to the Oncology Crisis in Gauteng Public Hospitals, Is There Any Hope Left for Inflammatory Breast Cancer Patients in South Africa? Inflammatory Breast Cancer (IBC) is certainly breast cancer. In fact, it’s a breast cancer overachiever. It is extremely rare, incredibly volatile and has a competitive spirit that makes
